How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

13,746 results for

Ages and Stages Questionnaire

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. Prospective evaluation of the Ages and Stages Questionnaire 3rd Edition in very-low-birthweight infants. (Full text)

Prospective evaluation of the Ages and Stages Questionnaire 3rd Edition in very-low-birthweight infants. To evaluate the predictive and concurrent diagnostic agreement of the Ages and Stages Questionnaire 3rd Edition (ASQ-3) with the Bayley Scales of Infant and Toddler Development 3rd Edition (Bayley-III) in infants born preterm and very-low-birthweight (PT/VLBW; ≤1250g).We evaluated 141 PT/VLBW infants (68 males, 73 females) born at the KK Women's and Children's Hospital between January 2010 (...) and December 2011, to determine predictive and concurrent diagnostic agreement between the ASQ-3 at 9, 12, 18, and 24 months corrected age and Bayley-III at 24 months. Cut-offs on the ASQ-3 at 24 months were estimated by receiver operating characteristic curves.Sixty (43%) and 25 (18%) failed in any domain of the ASQ-3 and Bayley-III (<70) respectively. A negative predictive value (NPV) >98% was achieved for the motor domain from 9 months, and >90% for the communication domain and the overall results at 24

2016 Developmental Medicine and Child Neurology PubMed abstract

22. Arabic Ages and Stages Questionnaire-III

Arabic Ages and Stages Questionnaire-III Arabic Ages and Stages Questionnaire-III - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Arabic Ages and Stages Questionnaire-III The safety and scientific validity (...) /treatment Child Development Behavioral: Arabic ASQ -3 Detailed Description: The Ages and Stages Questionnaires (ASQ) is a developmental screening questionnaire for parents to answer regarding their children's level of growth and development between the ages of 7 months and 3 years. This questionnaire was translated into Arabic in order to adapt it for the Arab speaking culture. For the first phase of this study, aiming to adapt and field-test this translated version, parents of eligible children

2015 Clinical Trials

23. Concurrent Validity of Ages and Stages Questionnaires in Preterm Infants (Abstract)

Concurrent Validity of Ages and Stages Questionnaires in Preterm Infants Although preterm infants born at 29 to 36 gestational weeks (GW) are at risk for developmental delay, they do not always benefit from systematic follow-up. Primary care physicians are then responsible for their developmental surveillance and need effective screening tests. This study aimed to determine whether the Ages and Stages Questionnaires (ASQ) at 12 and 24 months' corrected age (CA) identify developmental delay

2012 EvidenceUpdates

24. Pertuzumab for adjuvant treatment of HER2-positive early stage breast cancer

Pertuzumab for adjuvant treatment of HER2-positive early stage breast cancer P Pertuzumab for adjuvant treatment of ertuzumab for adjuvant treatment of HER2-positiv HER2-positive early stage breast cancer e early stage breast cancer T echnology appraisal guidance Published: 20 March 2019 nice.org.uk/guidance/ta569 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility (...) equality of opportunity and to reduce health inequalities. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Pertuzumab for adjuvant treatment of HER2-positive early stage breast cancer (TA569) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2

2019 National Institute for Health and Clinical Excellence - Technology Appraisals

25. Stages of Biological Development across Age: An Analysis of Canadian Health Measure Survey 2007–2011 (Full text)

Stages of Biological Development across Age: An Analysis of Canadian Health Measure Survey 2007–2011 The stages of biological development are not clearly defined despite the fact that they have been used to refer to concepts such as adolescence and aging. This study aimed to (1) propose and test a framework to search for stages of representative components and determine stages of stability and transition, (2) identify stages of biological development based on health questionnaire (...) ) analysis was conducted to summarize the data and the loadings were used to interpret the PCs. A stable stage was assumed to be the age groups without significantly different values of PCs.The CHMS interviewed 16,340 Canadians. Of all, 51.25% were female. The age ranged from 6 to 79 years (mean = 34.41 years, 95% CI = 34.74-34.08). The proportions of total variance explained by the first three PCs were 12.14, 4.03, and 3.19%, respectively. The differences of the first PC were not significant, especially

2018 Frontiers in public health PubMed abstract

26. Association of self-care status with some relevant factors in middle-aged women in their early menopausal stage (Full text)

Association of self-care status with some relevant factors in middle-aged women in their early menopausal stage Through self-care, people can solve their health-related problems through increasing their awareness and correcting their lifestyles.To determine the association of self-care status with some relevant factors in Kashanian middle-aged women in their early menopausal stage.This is a cross-sectional study on 351 women in the age range of 45-60 years. Women were selected based on cluster (...) sampling method from the individuals at health-care centers in Kashan, Iran. Researcher-constructed questionnaire on self-care was used. The validity and the reliability of the questionnaire were calculated. The information gathering method was questionnaire completion by the study participants or interview with them. Collected data were analyzed with SPSS 16 software. T-test, ANOVA, Spearman correlation, and linear regression analysis were applied.The mean (±standard deviation) of the self-care score

2018 Journal of education and health promotion PubMed abstract

27. Adequacy of nutrition and body weight in patients with early stage dementia: The cognition and aging study. (Abstract)

Adequacy of nutrition and body weight in patients with early stage dementia: The cognition and aging study. Recent evidence highlights the effects of obesity, diabetes and hypertension in the development of Alzheimer's disease. Involuntary body weight changes in patients with different stages of dementia can be related to clinical factors of the patient per se or support from their caregivers. Understanding the interactions among factors is important to establish a monitoring paradigm to guide (...) treatment strategies.A total of 345 patients with very mild (n = 224) and mild stage (n = 121) dementia were enrolled from a multi-disciplinary dementia clinic. Clinical data (comorbidities, Mini-Mental State Examination [MMSE] scores, neuropsychiatric inventory [NPI] scores, eating behavior questionnaire), nutritional state (Mini-Nutritional Assessment [MNA] or MNA short form [MNA-SF]) and body mass index (BMI) were recorded. Nutritional state and BMI served as the two major outcome measures

2018 Clinical nutrition (Edinburgh, Scotland)

28. Questionnaire Breakoff and Item Nonresponse in Web-Based Questionnaires: Multilevel Analysis of Person-Level and Item Design Factors in a Birth Cohort. (Full text)

age (adjusted odds ratio 1.40, 95% CI 1.05-1.88), lower educational level (adjusted odds ratio [OR] 1.53, 95% CI 1.23-1.90), and earlier stage of pregnancy (adjusted OR 3.01, 95% CI 2.31-3.92) were positively associated with questionnaire breakoff. Of the 1,062,519 applicable items displayed for the participants, 22,831 were not responded to (overall prevalence of item nonresponse 2.15%). Item nonresponse was positively associated with older age (adjusted OR 1.25, 95% CI 1.14-1.38), being (...) Questionnaire Breakoff and Item Nonresponse in Web-Based Questionnaires: Multilevel Analysis of Person-Level and Item Design Factors in a Birth Cohort. Web-based questionnaires are increasingly used in epidemiologic studies, as traditional methods are facing a decrease in response rates and an increase in costs. However, few studies have investigated factors related to the level of completion of internet-based epidemiologic questionnaires.Our objective was to identify person-level

2018 Journal of medical Internet research PubMed abstract

29. Adjuvant Systemic Chemotherapy for Stage II and III Colon Cancer Following Complete Resection

older than 70 years of age in any of three trials that performed this post hoc subgroup analysis [5,6, 8]. These studies have an unclear risk of bias as almost all domains in the Risk of Bias assessment were rated as either low or unclear risk of bias. Caution must be exercised when interpreting post hoc subgroup analyses. Interpretation of Evidence for Stage III Colon Cancer – Recommendations 4 and 5 ? There was agreement among the Working Group members that the overall certainty of the evidence (...) the recommendations as they believed that the toxicities were manageable given the increase in OS. ? The desirable effect (i.e., increased survival) is large. At the same time, the undesirable effects (toxicity) are manageable in this population. The Working Group believed the desirable effect (longer survival) is large relative to the undesirable effects (toxicity) in the selected group of stage III patients. ? The evidence is generalizable to the entire stage III population that is younger than 70 years of age

2019 Cancer Care Ontario

30. Protocol for a systematic review of patient reported outcome measures (PROMs) to inform item development for a new questionnaire of listening effort in cochlear implantation - the Listening Effort Questionnaire (LEQ)

Protocol for a systematic review of patient reported outcome measures (PROMs) to inform item development for a new questionnaire of listening effort in cochlear implantation - the Listening Effort Questionnaire (LEQ) Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated (...) are not reported or unclear, we will attempt to contact authors by e-mail (max. 2 attempts). In case an outcome is measured at multiple time points, data from the time point where efficacy is highest will be included. ">Methods for data extraction Example: Experimental groups, control group(s) and number of animals per group. ">Data to be extracted: study design Example: Species, sex, weight, age, co‐morbidity, anaesthetic agent used, method of induction of cardiac ischemia, duration of ischemia and duration

2017 PROSPERO

31. How can primary care interventions increase the uptake of physical activity for people at different stages of life?

intention was to produce three Evidence Briefings, one for different stages of the life-course: young adults, people of working age, and older people. However, while there are sufficient papers about primary care interventions for increasing uptake of physical activity in adults of any age, evidence for the individual stages is scarce, and therefore, one EB has been produced, summarising the literature identified, and highlighting existing programmes. A literature search was conducted, and 79 highly (...) ). People suffering from chronic musculoskeletal pain found it particularly hard to undertake PA. Individually tailored PA prescriptions can help them overcome some obstacles enabling them to participate in PA (31, 32). How can primary care interventions increase the uptake of physical activity for people at different stages of life? KLS Evidence Briefing 18 th April 2018 Interventions – all ages Physical Activity Prescription Physical Activity Prescriptions (PAP) are provided by PCS, who signpost

2018 Publication 4890972

32. Diagnosis and Treatment of Early Stage Testicular Cancer

tumor marker (hCG, AFP and LDH) levels obtained prior to the initiation of chemotherapy, staging imaging studies, and tumor histology following radical orchiectomy (Strong Recommendation; Evidence Level: Grade A). Any post-pubertal male, regardless of age, should be treated according to adult treatment guidelines. (Moderate Recommendation; Evidence Level: Grade B) 17. For patients in whom serum tumor marker (AFP and hCG) levels are borderline elevated (within 3x upper limit of normal) post (...) populations 5,6 Age-adjusted incidence has nearly doubled over the last 4 decades for unknown reasons, from 3.7 per 100,000 in 1975 to 6.4 per 100,000 in 2014. 5 A stage migration of GCT has been observed, presumably due to increased awareness and earlier diagnosis. Between 1973 and 2014, the percentage of tumors diagnosed at a localized stage increased from 55% to 68% in the United States. Currently, less than 15% of men present with stage III disease (to the lungs, viscera, or non-regional lymph nodes

2019 American Urological Association

33. Dabrafenib (Tafinlar) - In combination with trametinib for the adjuvant treatment of adult patients with Stage III melanoma with a BRAF V600 mutation

and often affects people of working age. Different activating mutations have been described in melanoma and approximately 45% of patients with cutaneous melanoma carry a BRAF V600 mutation. Melanoma can be curable if recognised and treated with surgery at an early stage however prognosis for patients with advanced melanoma is poor with 5- year survival between 40% and 80%. 3, 6 Interferon alfa is licensed in Scotland for the treatment of resected melanoma in the adjuvant setting, but is not recommended (...) Dabrafenib (Tafinlar) - In combination with trametinib for the adjuvant treatment of adult patients with Stage III melanoma with a BRAF V600 mutation 1 Published 11 February 2019 1 SMC2131 dabrafenib 50mg and 75mg hard capsules (Tafinlar®) Novartis Pharmaceuticals UK Ltd In confidence 11 January 2019 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and advises NHS Boards and Area Drug and Therapeutic Committees (ADTCs) on its use in NHSScotland

2019 Scottish Medicines Consortium

34. Developmental screening in a Canadian First Nation (Mohawk): psychometric properties and adaptations of ages & stages questionnaires (2nd edition). (Full text)

Developmental screening in a Canadian First Nation (Mohawk): psychometric properties and adaptations of ages & stages questionnaires (2nd edition). The need for early intervention tools adapted to the First Nation culture is well documented. However, standards derived from First Nation communities are absent from the literature. This study examines the psychometric properties of an adaptation of a caregiver-completed screening tool, the Ages & Stages Questionnaires (ASQ), for the Mohawk (...) population.Participants who completed the questionnaires include 17 teachers, along with the parents of 282 children (130 girls and 152 boys) between the ages of 9 and 66 months who attend the Child and Family Center Mohawk Territory, Quebec.For the internal consistency of the four questionnaires (36-, 42-, 48- and 54-month intervals), Cronbach's alphas varied between .61 and .84. Five results were below 0.60: "gross motor" (Q36 and Q42), "problem solving" (Q36) and "personal-social" (Q36 and Q42). A comparison

2014 BMC Pediatrics PubMed abstract

35. Adaptation of the Ages and Stages Questionnaire for Remote Aboriginal Australia. (Abstract)

Adaptation of the Ages and Stages Questionnaire for Remote Aboriginal Australia. A key challenge to providing quality developmental care in remote Aboriginal primary health care (PHC) centers has been the absence of culturally appropriate developmental screening instruments. This study focused on the cross-cultural adaptation of the Ages and Stages Questionnaires, 3rd edition (ASQ-3), with careful attention to language and culture. We aimed to adapt the ASQ-3 for use with remote dwelling

2014 Qualitative Health Research

36. Development and validation of the Salzburg COPD-screening questionnaire (SCSQ): a questionnaire development and validation study (Full text)

and validated chronic obstructive pulmonary disease questionnaire to increase the pre-test probability for chronic obstructive pulmonary disease diagnosis in subjects undergoing confirmatory spirometry. In 2005, we completed the Austrian Burden of Obstructive Lung Disease-study in 1258 subjects aged >40 years. Post-bronchodilator spirometry was performed, and non-reversible airflow limitation defined by FEV1/FVC ratio below the lower limit of normal. Questions from the Salzburg chronic obstructive pulmonary (...) obstructive pulmonary disease screening questionnaire was derived from the highly standardized Burden of Obstructive Lung Disease study. This validated and easy to use questionnaire can help to increase the efficiency of chronic obstructive pulmonary disease case-finding.QUESTIONNAIRE FOR PRE-SCREENING POTENTIAL SUFFERERS: Scientists in Austria have developed a brief, simple questionnaire to identify patients likely to have early-stage chronic lung disease. Chronic obstructive pulmonary disease (COPD

2017 NPJ primary care respiratory medicine PubMed abstract

37. Screening for impaired vision in community-dwelling adults aged 65 years and older in primary care settings

to deter- mine the quality of evidence and strength of recommendation (Box 1). The evidence-to-decision framework is provided in Appendix 2 (available at www.cmaj.ca/lookup/suppl/doi:10.1503/ cmaj.171430/-/DC1). The Knowledge Translation team at St. Michael’s Hospital (Toronto, Ontario) engaged members of the public on behalf of the task force at two stages of guideline development. In the first phase, 15 participants aged 58 to 78 years rated outcomes to inform the systematic review, by means (...) Screening for impaired vision in community-dwelling adults aged 65 years and older in primary care settings E588 CMAJ | MAY 14, 2018 | VOLUME 190 | ISSUE 19 © 2018 Joule Inc. or its licensors I mpaired vision is an important health burden in both devel- oped and developing countries, particularly among older adults. 1 The 2006 Participation and Activity Limitation Survey found that 13% of Canadians aged 75 years and older had a “see- ing limitation,” with 31% described as severe, compared

2018 CPG Infobase

38. Tiotropium (Spiriva Respimat) add-on maintenance bronchodilator treatment in patients aged 6 years and older with severe asthma

Tiotropium (Spiriva Respimat) add-on maintenance bronchodilator treatment in patients aged 6 years and older with severe asthma Tiotropium (Spiriva ® Respimat ® ). Reference number 1882. Page 1 of 3 AWMSG Secretariat Assessment Report – Limited submission Tiotropium (Spiriva ® Respimat ® ) 2.5 microgram, inhalation solution Company: Boehringer Ingelheim Ltd Licensed indication under consideration: add-on maintenance bronchodilator treatment in patients aged 6 years to < 18 years with severe (...) -on maintenance bronchodilator treatment in adult patients with asthma who are currently treated with the maintenance combination of inhaled corticosteroids (= 800 micrograms budesonide per day or equivalent) and long-acting ß2 agonists and who experienced one or more severe exacerbations in the previous year. This submission covers the licence extension to include patients aged 6 years to < 18 years. The whole licenced indication wording was revised at the time of the paediatric licence extension and is now

2018 All Wales Medicines Strategy Group

39. ESMO–ESGO Consensus Conference Recommendations on Ovarian Cancer: Pathology and Molecular Biology, Early and Advanced Stages, Borderline Tumours and Recurrent Disease

ESMO–ESGO Consensus Conference Recommendations on Ovarian Cancer: Pathology and Molecular Biology, Early and Advanced Stages, Borderline Tumours and Recurrent Disease SPECIAL ARTICLE ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease † N. Colombo 1 * , C. Sessa 2 , A. du Bois 3 , J. Ledermann 4 , W. G. McCluggage 5 , I. McNeish 6 , P. Morice 7 , S. Pignata 8 , I. Ray-Coquard 9 , I (...) jointlydevelopedclinicallyrelevant andevidence-based recommendationsinseveralselectedareas inorderto improvethequalityofcare forwomenwithovariancancer. TheESMO– ESGO consensusconferenceonovariancancerwasheldon 12–14April2018inMilan,Italy,andcomprisedamultidisciplinary panelof 40leadingexpertsin themanagementofovariancancer. Beforetheconference,the expertpanel workedonfive clinically relevantquestions regardingovariancancerrelating toeachofthefollowingfour areas:pathologyandmolecular biology,early-stage andborderlinetumours

2019 European Society for Medical Oncology

40. The diagnostic accuracy of screening questionnaires for obstructive sleep apnea in children: a systematic review and meta-analysis

The diagnostic accuracy of screening questionnaires for obstructive sleep apnea in children: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record (...) software. In case data are not reported or unclear, we will attempt to contact authors by e-mail (max. 2 attempts). In case an outcome is measured at multiple time points, data from the time point where efficacy is highest will be included. ">Methods for data extraction Example: Experimental groups, control group(s) and number of animals per group. ">Data to be extracted: study design Example: Species, sex, weight, age, co‐morbidity, anaesthetic agent used, method of induction of cardiac ischemia

2019 PROSPERO

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>